Ampicillin/sulbactam	Cefuroxime	Post-cesarean endometritis	-1	-1	<td align="left">Post-cesarean endometritis, n (%)</td><td align="center">4 (2.3)</td><td align="center">2 (2.4)</td><td align="center">2 (2.2)</td><td align="center">1</td>
Ampicillin/sulbactam	Cefuroxime	Duration of hospitalization	-1	-1	Duration of hospitalization in days, median (IQR) <TAB> 4 (4-4) <TAB> 4 (4-5) <TAB> 4 (4-4) <TAB> 0.09
Ampicillin/sulbactam	Cefuroxime	Postoperative infection	12811	13002	Postoperative infections developed in 13 (7.4%) patients; five out of 85 (5.9%) patients that received cefuroxime and 8 out of 91 (8.8%) patients that received ampicillin-sulbactam (p = 0.6).
Ampicillin/sulbactam	Cefuroxime	Post-cesarean endometritis	-1	-1	Post-cesarean endometritis, n (%) <TAB> 4 (2.3) <TAB> 2 (2.4) <TAB> 2 (2.2) <TAB> 1
Ampicillin/sulbactam	Cefuroxime	Duration of hospitalization	-1	-1	<td align="left">Duration of hospitalization in days, median (IQR)</td><td align="center">4 (4-4)</td><td align="center">4 (4-5)</td><td align="center">4 (4-4)</td><td align="center">0.09</td>
Ampicillin/sulbactam	Cefuroxime	Postoperative infection	-1	-1	All post-op infections, n (%) <TAB> 13 (7.4) <TAB> 5 (5.9) <TAB> 8 (8.8) <TAB> 0.6
